Supplementary Figure 5 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

MLA

Stephen J. Russell, et al. Supplementary Figure 5 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....189ef8edb0c43644ba9b3406b3c6443e&authtype=sso&custid=ns315887.

APA

Stephen J. Russell, Kah-Whye Peng, Mark J. Federspiel, Timothy O. Wilson, C. Robert Stanhope, Sean C. Dowdy, Karl C. Podratz, Pamela J. Atherton, Gary Keeney, Jeff A. Sloan, Paula J. Zollman, Ileana Aderca, Paul J. Haluska, Judith S. Kaur, Brigitte A. Barrette, Prema P. Peethambaram, Harry J. Long, William A. Cliby, Lynn C. Hartmann, & Evanthia Galanis. (2023). Supplementary Figure 5 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer.

Chicago

Stephen J. Russell, Kah-Whye Peng, Mark J. Federspiel, Timothy O. Wilson, C. Robert Stanhope, Sean C. Dowdy, Karl C. Podratz, et al. 2023. “Supplementary Figure 5 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....189ef8edb0c43644ba9b3406b3c6443e&authtype=sso&custid=ns315887.